Antimüllerian hormone levels are lower in BRCA2 mutation carriers

BRCA2 mutation carriers have antimullerian hormone (AMH) levels that are significantly lower than healthy low-risk control women and have increased odds of having low AMH levels.

Volume 107, Issue 5, Pages 1256–1265.e6

Authors:

Lauren Johnson, M.D., M.S.C.E, Mary D. Sammel, Sc.D., Susan Domchek, M.D., Allison Schanne, B.A., Maureen Prewitt, B.S.N., Clarisa Gracia, M.D., M.S.C.E.

Abstract:

Comments

Go to the profile of Dr Elena Kontogianni
about 5 years ago
Should we conceded oocyte freezing to BRCA2 carriers? Is their fertility in general lower than brca2 non-carriers?